ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Philippe Icard
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Courtheoux, P.
Right arrow Articles by Icard, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Courtheoux, P.
Right arrow Articles by Icard, P.
Related Collections
Right arrow Great vessels

Ann Thorac Surg 2003;75:158-161
© 2003 The Society of Thoracic Surgeons

Original article: cardiovascular

Stent placement in superior vena cava syndrome

Patrick Courtheoux, MDa, Barbara Alkofer, MDb, Madjed Al Refaï, MDb, Radj Gervais, MDc, Jean Philippe Le Rochais, MDb, Philippe Icard, MD*b

a Department of Neuroradiology, CHRU de Caen, Caen, France
b Department of Thoracic Cardiovascular Surgery, CHRU de Caen, Caen, France
c Department of Thoracic Oncology, Centre François Baclesse, Caen, France

Accepted for publication August 13, 2002.

* Address reprint requests to Dr Icard, Department of Thoracic and Cardiovascular Surgery, CHRU de Caen, Côte de Nacre, 14033 Caen, France.
e-mail: icard-p{at}chu-caen.fr

BACKGROUND: Superior vena cava syndrome (SVCS) is often seen in the natural history of malignant thoracic diseases. SVCS is characterized by unpleasant symptoms that usually lead to death. The purpose of our study is to show the efficiency of percutaneous stenting in the superior vena cava for relieving SVCS and the possibility of repeated stenting after recurrence.

METHODS: Twenty patients with SVCS caused by malignant diseases who had one or more stents placed in the superior vena cava or its main tributaries were evaluated.

RESULTS: Out of 20 patients, 1 died of myocardial infarction 24 hours after the procedure without any signs of pulmonary embolus, hemorrhage, or malposition of the stent. SVCS was successfully controlled in 94% of patients until death or completion of the study. In 3 patients the procedure was repeated (3 to 20 weeks later) because of the recurrence of symptoms.

CONCLUSIONS: Percutaneous venous stent placement in the superior vena cava is a simple and effective technique to relieve rapid SVCS caused by malignancies. When recurrence occurs, repeated stenting can be performed successfully.




This article has been cited by other articles:


Home page
 ChestHome page
P. A. Kvale, P. A. Selecky, and U. B. S. Prakash
Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 368S - 403S.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
L. D. Wilson, F. C. Detterbeck, and J. Yahalom
Superior Vena Cava Syndrome with Malignant Causes
N. Engl. J. Med., May 3, 2007; 356(18): 1862 - 1869.
[Full Text] [PDF]

Home page
 AM J HOSP PALLIAT CAREHome page
A. R. Haas
Recent Advances in the Palliative Management of Respiratory Symptoms in Advanced-Stage Oncology Patients
American Journal of Hospice and Palliative Medicine, April 1, 2007; 24(2): 144 - 151.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.